Functional Sarcoplasmic Reticulum for Calcium Handling of Human Embryonic Stem Cell-Derived Cardiomyocytes: Insights for Driven Maturation
- 13 September 2007
- journal article
- research article
- Published by Oxford University Press (OUP) in Stem Cells
- Vol. 25 (12) , 3038-3044
Abstract
Cardiomyocytes (CMs) are nonregenerative. Self-renewable pluripotent human embryonic stem cells (hESCs) can differentiate into CMs for cell-based therapies. In adult CMs, Ca2+-induced Ca2+ release from the sarcoplasmic reticulum (SR) via the ryanodine receptor (RyR) is key in excitation-contraction coupling. Therefore, proper Ca2+ handling properties of hESC-derived CMs are required for their successful functional integration with the recipient heart. Here, we performed a comprehensive analysis of CMs differentiated from the H1 (H1-CMs) and HES2 (HES2-CMs) hESC lines and human fetal (F) and adult (A) left ventricular (LV) CMs. Upon electrical stimulation, all of H1-, HES2-, and FLV-CMs generated similar Ca2+ transients. Caffeine induced Ca2+ release in 65% of FLV-CMs and ∼38% of H1- and HES2-CMs. Ryanodine significantly reduced the electrically evoked Ca2+ transient amplitudes of caffeine-responsive but not -insensitive HES2- and H1-CMs and slowed their upstroke; thapsigargin, which inhibits the sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) pump, reduced the amplitude of only caffeine-responsive HES2- and H1-CMs and slowed the decay. SERCA2a expression was highest in ALV-CMs but comparable among H1-, HES2-, and FLV-CMs. The Na+-Ca2+ exchanger was substantially expressed in both HES2- and H1-CMs relative to FLV- and ALV-CMs. RyR was expressed in HES2-, H1-, and FLV-CMs, but the organized pattern for ALV-CMs was not observed. The regulatory proteins junctin, triadin, and calsequestrin were expressed in ALV-CMs but not HES2- and H1-CMs. We conclude that functional SRs are indeed expressed in hESC-CMs, albeit immaturely. Our results may lead to driven maturation of Ca2+ handling properties of hESC-CMs for enhanced contractile functions. Disclosure of potential conflicts of interest is found at the end of this article.Keywords
This publication has 35 references indexed in Scilit:
- Human Embryonic Stem Cell-Derived Cardiomyocytes for Heart TherapiesCardiovascular & Hematological Disorders-Drug Targets, 2007
- Functional Integration of Electrically Active Cardiac Derivatives From Genetically Engineered Human Embryonic Stem Cells With Quiescent Recipient Ventricular CardiomyocytesCirculation, 2005
- Electromechanical integration of cardiomyocytes derived from human embryonic stem cellsNature Biotechnology, 2004
- Human Embryonic Stem Cells Develop Into Multiple Types of Cardiac MyocytesCirculation Research, 2003
- Differentiation of Human Embryonic Stem Cells to CardiomyocytesCirculation, 2003
- Characterization and Enrichment of Cardiomyocytes Derived From Human Embryonic Stem CellsCirculation Research, 2002
- Local Ca2+ Signaling and EC Coupling in Heart: Ca2+ Sparks and the Regulation of the [Ca2+]i TransientJournal of Molecular and Cellular Cardiology, 2002
- Cardiac excitation–contraction couplingNature, 2002
- Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytesJournal of Clinical Investigation, 2001
- Embryonic Stem Cell Lines Derived from Human BlastocystsScience, 1998